DBD DIEBOLD NIXDORF, InccompanySEC Filings & Insider Trading Activity 2026
Latest DIEBOLD NIXDORF, Inc (DBD) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 12, 2026, a 10-Q quarterly report filed on April 30, 2026, an 8-K current report filed on July 29, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for DIEBOLD NIXDORF, Inc (DBD) (SEC CIK 28823), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on DIEBOLD NIXDORF, Inc
Ask AI about DBD filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting DBD positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on DBD.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of DIEBOLD NIXDORF, Inc (DBD) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $3.8B | $3.8B |
| Gross Profit | $520.0M | $920.0M | $961.2M |
| Operating Income | - | $182.1M | $242.0M |
| Net Income | $1.4B | -$16.5M | $94.6M |
| Gross Margin | - | 24.5% | 25.3% |
| Op. Margin | - | 4.9% | 6.4% |
| Net Margin | - | -0.4% | 2.5% |
| Balance Sheet | |||
| Total Assets | $4.2B | $3.5B | $3.9B |
| Equity | - | $929.8M | $1.1B |
| ROE | - | -1.8% | 8.6% |
| Per Share | |||
| EPS | $16.69 | $-0.44 | $2.54 |
| Cash Flow | |||
| Operating CF | - | $149.2M | $300.7M |
Source: XBRL financial data from DIEBOLD NIXDORF, Inc (DBD) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 29, 2026 | - | - | - |
8-K | May 26, 2026 | - | - | |
8-K | Apr 30, 2026 | - | - | - |
10-Q | Apr 30, 2026 | Mar 31, 2026 | - | |
8-K | Feb 25, 2026 | - | Analysis | - |
10-K | Feb 12, 2026 | Dec 31, 2025 | - | |
8-K | Feb 12, 2026 | - | - | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 6, 2025 | Jun 30, 2025 | - | |
10-Q | May 7, 2025 | Mar 31, 2025 | - | |
10-K | Feb 25, 2025 | Dec 31, 2024 | - | |
SC 13G | Nov 8, 2024 | - | - | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | - | |
SC 13G | Oct 24, 2024 | - | - | |
10-Q | Aug 7, 2024 | Jun 30, 2024 | - | |
10-Q | May 2, 2024 | Mar 31, 2024 | - | |
10-K | Mar 8, 2024 | Dec 31, 2023 | - | |
10-Q | Nov 9, 2023 | Sep 30, 2023 | - | |
SC 13D | Aug 21, 2023 | - | - | |
SC 13D | Aug 21, 2023 | - | - | |
SC 13D | Aug 21, 2023 | - | - | |
SC 13D | Aug 18, 2023 | - | - | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | - | |
10-Q | May 30, 2023 | Mar 31, 2023 | - | |
10-K | Mar 16, 2023 | Dec 31, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate DBD share value held by 13F filers tracked by SignalX, by quarter.
- Dimensional Fund Advisors+165.3K (+17%)
- Millennium Management+87.6K (+961%)
- Goldman Sachs Group+49.9K (+52%)
- AQR Capital Management+38.6K (+89%)
- Citadel Advisors LLC+38.3K (+46%)
- BlackRock95.2K (-5%)
- Renaissance Technologies LLC27.9K (-27%)
- Two Sigma Investments23.5K (-30%)
- Wells Fargo & Co18.7K (-61%)
- Morgan Stanley14.3K (-9%)
- Franklin Resources+82.0K
- Coatue Management+3.0K
- Fifth Third Bancorp+28
- Vanguard Group Inc−1.96M
- Invesco Ltd−125.9K
- JPMorgan Chase & Co−66.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 161 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest DBD SEC filings in 2026?
DIEBOLD NIXDORF, Inc (DBD) has filed a 10-K annual report on February 12, 2026, a 10-Q quarterly report on April 30, 2026, an 8-K current report on July 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did DBD file its most recent 10-K annual report?
DIEBOLD NIXDORF, Inc (DBD) filed its most recent 10-K annual report on February 12, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view DBD 10-Q quarterly reports?
DIEBOLD NIXDORF, Inc (DBD)'s most recent 10-Q quarterly report was filed on April 30, 2026. SignalX displays every DBD 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has DBD filed recently?
DIEBOLD NIXDORF, Inc (DBD)'s most recent 8-K was filed on July 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find DBD insider trading activity (Form 4)?
SignalX aggregates every DBD Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does DBD file with the SEC?
DIEBOLD NIXDORF, Inc (DBD) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new DBD filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for DIEBOLD NIXDORF, Inc (DBD).
What is DBD's SEC CIK number?
DIEBOLD NIXDORF, Inc (DBD)'s SEC CIK (Central Index Key) number is 28823. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 28823 to look up all DBD filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find DBD return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from DIEBOLD NIXDORF, Inc (DBD) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of DIEBOLD NIXDORF, Inc SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 63+ filings.